These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6428143

  • 1. Clinical evaluation of deprenyl (selegiline) in the treatment of Parkinson's disease.
    Csanda E, Tárczy M.
    Acta Neurol Scand Suppl; 1983; 95():117-22. PubMed ID: 6428143
    [Abstract] [Full Text] [Related]

  • 2. L-deprenyl in the treatment of Parkinson's disease.
    Csanda E, Tárczy M, Takáts A, Mogyorós I, Köves A, Katona G.
    J Neural Transm Suppl; 1983; 19():283-90. PubMed ID: 6421993
    [Abstract] [Full Text] [Related]

  • 3. (-)Deprenyl in the treatment of decompensated Parkinson's disease.
    Csanda E, Tárczy M, Takáts A.
    J Neural Transm Suppl; 1986; 22():247-52. PubMed ID: 3097259
    [Abstract] [Full Text] [Related]

  • 4. Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experience.
    Birkmayer W, Birkmayer GD.
    J Neural Transm Suppl; 1986; 22():219-25. PubMed ID: 3097256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. L-deprenyl treatment of on-off phenomena in Parkinson's disease.
    Rinne UK, Siirtola T, Sonninen V.
    J Neural Transm; 1978; 43(3-4):253-62. PubMed ID: 745018
    [No Abstract] [Full Text] [Related]

  • 10. The effect of R-(-)-deprenyl in de novo Parkinson patients on combination therapy with levodopa and decarboxylase inhibitor.
    Przuntek H, Kuhn W.
    J Neural Transm Suppl; 1987; 25():97-104. PubMed ID: 3123607
    [Abstract] [Full Text] [Related]

  • 11. Deprenyl (selegiline) combined with levodopa and a decarboxylase inhibitor in the treatment of Parkinson's disease.
    Presthus J, Hajba A.
    Acta Neurol Scand Suppl; 1983; 95():127-33. PubMed ID: 6428145
    [Abstract] [Full Text] [Related]

  • 12. R-(-)-deprenyl and parkinsonism.
    Yahr MD.
    J Neural Transm Suppl; 1987; 25():5-12. PubMed ID: 3123605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long term treatment with L-deprenyl.
    Birkmayer W.
    J Neural Transm; 1978; 43(3-4):239-44. PubMed ID: 745016
    [No Abstract] [Full Text] [Related]

  • 15. Double-blind trial of R-(-)-deprenyl for the "on-off" effect complicating Parkinson's disease.
    Golbe LI, Duvoisin RC.
    J Neural Transm Suppl; 1987; 25():123-9. PubMed ID: 3123598
    [Abstract] [Full Text] [Related]

  • 16. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study.
    Birkmayer W, Knoll J, Riederer P, Youdim MB, Hars V, Marton J.
    J Neural Transm; 1985; 64(2):113-27. PubMed ID: 3935752
    [Abstract] [Full Text] [Related]

  • 17. New approaches in the use of selegiline for the treatment of Parkinson's disease.
    Lees AJ, Frankel J, Eatough V, Stern GM.
    Acta Neurol Scand Suppl; 1989; 126():139-45. PubMed ID: 2515719
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deprenyl in Parkinson disease: personal experience.
    Giovannini P, Grassi MP, Scigliano G, Piccolo I, Soliveri P, Caraceni T.
    Ital J Neurol Sci; 1985 Jun; 6(2):207-12. PubMed ID: 3928526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.